logo

Search

Login | Create Account

rheumatology


Categories

Bone health Gout JIA Lupus Medicines Medicopolitical Musculoskeletal Osteoarthritis Pain Psoriatic arthritis Public health Rare diseases Research Rheumatoid arthritis Risk factors Scleroderma Spondyloarthritis

Other

Conferences

Specialties


Cardiology Dermatology Endocrinology Gastroenterology Haematology Neurology Oncology Respiratory Rheumatology

General


Contact Us About Us Website Disclaimer Privacy Policy Terms & Conditions

©2022 the limbic

logo

#ACR18

Sunday 21st - Wednesday 24th October 2018

Osteoarthritis

Can shoe-stiffening insoles reduce progression of OA in first MTP joint?

 Carbon-fibre insoles for shoes, which can reduce the range of motion at the first metatarsophalangeal (MTP) joint, have been shown to be useful in reducing pain associated with osteoarthritis of...

 Carbon-fibre insoles for shoes, which can reduce the range of...


Spondyloarthritis

Australian team’s new genetic risk score identifies early ankylosing spondylitis

Polygenic risk scores may help identify ankylosing spondylitis earlier and at a lower cost than current testing methods, according to Australian research presented at the 2018 ACR/ARHP Annual Meeting in Chicago. The genetic risk score (GRS) uses thousands of genetic variants...

Polygenic risk scores may help identify ankylosing spondylitis earlier and at a lower cost than current testing methods, according to...


Scleroderma

Long term results show superiority of HSCT in severe scleroderma

Long-term follow-up of patients receiving hematopoietic stem cell transplantation (HSCT) for severe scleroderma has confirmed a durable survival benefit compared to conventional treatment with cyclophosphamide. The findings, presented at the 2018 ACR/ARHP Annual Meeting in Chicago, extend the findings from...

Long-term follow-up of patients receiving hematopoietic stem cell transplantation (HSCT) for severe scleroderma has confirmed a durable survival benefit compared...


Cancel
Cancel